These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39008598)

  • 1. Latest research in nootropic therapy of patients with chronic cerebral circulation insufficiency.
    Chernii TV; Cherniy VI; Svitlytska DV
    Wiad Lek; 2024; 77(5):1063-1068. PubMed ID: 39008598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
    Lee W; Kim M
    Medicine (Baltimore); 2024 Jun; 103(24):e38067. PubMed ID: 38875437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined therapy of cerebrovascular disorders with neuroprotectors].
    Putilina MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):58-63. PubMed ID: 28091502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of cerepro (choline alfoscerate) in the treatment of outpatients with chronic progressive cerebrovascular disease].
    Kostenko EV; Petrova LV; Artemova IIu; Vdovichenko TV; Ganzhula PA; Ismailov AM; Lisenker LN; Petrov SV; Otcheskaia OV; Rotor LD; Khozova AA; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 1):24-30. PubMed ID: 22677751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of choline alfoscerate effectiveness in chronic ocular ischemic syndrome].
    Kamilov KМ; Kasimova MS; Makhkamova DК
    Vestn Oftalmol; 2016; 132(2):73-76. PubMed ID: 27213801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Montreal cognitive assessment and analysis of related factors for cognitive impairment in patients with chronic cerebral circulation insufficiency.
    Zhang L; Dong W; Han J; Wang Z; Sun D; Ji X; Li M; Zhang B
    Int J Psychiatry Med; 2015; 50(3):257-70. PubMed ID: 26561273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
    Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
    J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of neuroprotectors with choline-positive action on the level of brain-injury markers during acute ischemic stroke].
    Vaizova OE; Zautner NA; Alifirova VM; Vengerovskiĭ AI
    Eksp Klin Farmakol; 2012; 75(3):7-9. PubMed ID: 22679745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
    Fioravanti M; Yanagi M
    Cochrane Database Syst Rev; 2005 Apr; (2):CD000269. PubMed ID: 15846601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Choice of neuroprotective therapy regimens in patients with chronic cerebral ischemia, taking into account the synergy of drug interactions].
    Gromova OA; Torshin IY; Putilina MV; Semenov VA; Rudakov KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8):42-50. PubMed ID: 32929923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
    Fioravanti M; Yanagi M
    Cochrane Database Syst Rev; 2004; (2):CD000269. PubMed ID: 15106147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
    Fioravanti M; Yanagi M
    Cochrane Database Syst Rev; 2000; (4):CD000269. PubMed ID: 11034681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies].
    Bagoly E; Fehér G; Szapáry L
    Orv Hetil; 2007 Jul; 148(29):1353-8. PubMed ID: 17631470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
    Fioravanti M; Yanagi M
    Cochrane Database Syst Rev; 2000; (2):CD000269. PubMed ID: 10796523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of CT perfusion imaging in chronic cerebral circulatory insufficiency and its relationship with crossed cerebellar diaschisis].
    Liu SL; Wang Y; Zhang Y; Xu HL; Wang JC; He WW; Qin XT; Cao GQ; Yang YJ; Zhuge QC; Chen WJ
    Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(5):359-364. PubMed ID: 28219193
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment by medicine which improves cerebral circulation and metabolism].
    Katsumata T; Katayama Y
    Nihon Rinsho; 2006 Nov; 64 Suppl 8():81-4. PubMed ID: 17469538
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of oral traditional Chinese patent medicine for chronic cerebral circulation insufficiency patients: A protocol for a systematic review and network meta-analysis.
    Xu Z; Feng X; Li L; Hu Z; Xiao Y; Jin G; Liao W
    Medicine (Baltimore); 2019 Jul; 98(27):e16175. PubMed ID: 31277122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyzing the neuropsychological characteristics and changes in serum markers of patients with chronic cerebral circulation insufficiency.
    Tang J; Zhen Y; Yu L; Lv C; Zheng J; Liang H
    Rev Assoc Med Bras (1992); 2018 Jan; 64(1):41-46. PubMed ID: 29561941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and safety of choline alfoscerate in the preventive therapy of dementia in elderly patients with Mild Cognitive Impairment: a three-year prospective comparative study].
    Ponomareva EV; Androsova LV; Krinsky SA; Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4. Vyp. 2):92-99. PubMed ID: 38696157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complex application 2-ethyl-6-methyl-3-hydroxypyridine-succinate and vinpocetine in cerebrovascular disorder.].
    Solovyeva EY; Karneev AN; Chekanov AV; Baranova OA; Choi IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):103-108. PubMed ID: 28638040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.